SG Americas Securities’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-88,600
Closed -$91K 3697
2025
Q4
$91K Hold
88,600
﹤0.01% 3261
2025
Q3
$116K Hold
88,600
﹤0.01% 3021
2025
Q2
$307K Buy
88,600
+14,800
+20% +$2.23M ﹤0.01% 1991
2025
Q1
$485K Buy
+73,800
New +$9.72M ﹤0.01% 1801
2017
Q2
Sell
-15,100
Closed -$29K 3511
2017
Q1
$29K Hold
15,100
﹤0.01% 3163
2016
Q4
$69K Buy
+15,100
New +$271K ﹤0.01% 2910
2016
Q1
Sell
-106,000
Closed -$1.6M 3241
2015
Q4
$1.6M Buy
+106,000
New +$3.48M 0.01% 846

Other funds holding THC

SG Americas Securities's THC Position: Q2 2026 in Review

SG Americas Securities increased its Tenet Healthcare (THC) stake by 19% in Q2 2026, buying an estimated $4.08M and bringing the position to 139,353 shares worth $26.1M. The position accounts for 0.01% of the portfolio, ranked #525.

SG Americas Securities first reported a position in THC in Q2 2013 and has held it in 50 quarters since. The position peaked at $34.5M in Q4 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • SG Americas Securities held 139,353 shares of Tenet Healthcare worth $26.1M as of Q2 2026.
  • SG Americas Securities bought 22,192 Tenet Healthcare shares in Q2 2026, an estimated $4.08M.
  • Tenet Healthcare made up 0.01% of SG Americas Securities's portfolio in Q2 2026, its #525 holding.
  • SG Americas Securities first reported a position in Tenet Healthcare in Q2 2013 and has held it in 50 quarters since.
  • SG Americas Securities's Tenet Healthcare position peaked at $34.5M in Q4 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.